In situ studies of orbital tissue from patients with thyroid-associated ophthalmopathy

Orbit

Volumn 15, Issue 3, 1996, Pages 147-158

  Hiromatsu, Yuji ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion molecules; Antigen; Heat shock proteins; HLA DR; Immunohistochemistry; In situ hybridization; Lymphocyte phenotype; PCR

Indexed keywords

AUTOANTIGEN; CELL ADHESION MOLECULE; HEAT SHOCK PROTEIN; HLA DR ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE; ORBIT DISEASE; POLYMERASE CHAIN REACTION;

EID: 0029811080     PISSN: 01676830     EISSN: None     Source Type: Journal    
DOI: 10.3109/01676839609150232     Document Type: Article

References (57)

1. Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D. Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12:150-153.
2. Weetman AP. Thyroid-associated eye disease: Pathophysiology. Lancet 1991; 338:25-28.
3. Gorman CA. Pathogenesis of Graves' ophthalmopathy. Thyroid 1994; 4:379-383.
4. Hiromatsu Y, Tanaka K, Ishisaka N, et al. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. J Clin Endocrinol Metabol 1995; 80: 685-691.
5. Dong Q, Ludgate M, Vassart G. Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease, expressed in the thyroid and extraocular muscle. J Clin Endocrinol Metabol 1991; 72:1375-1381.
6. Yoshikawa K, Higashide T, Nakase Y, Inoue T, Inoue Y, Shiga H. Role of reclus muscle enlargement in clinical profile of dysthyroid ophthalmopathy. Jpn J Ophthalmol 1991; 35:175-181.
7. Hiromatsu Y, Kojima K, Ishisaka N, et al. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 1992; 2:299-305.
8. Rieber EP. T-cell section report. In: Knapp W, Dorken B, Gilks WR et al. (editors). Leukocyte Typing IV: White Cell Differentiation Antigens. New York: Oxford University Press, 1989; 229-249.
9. Gross B, Misrahi M, Sar S, Milgrom E. Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun 1991; 177:679-687.
10. Tanaka K, Hiromatsu Y, Sato M, Inoue Y, Nonaka K. Localization of heat shock protein in orbital tissue from patients with Graves' ophthalmopathy using in situ hybridization. Life Sci 1994; 54:355-359.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162:156-159.
12. Tokunaga K, Nakamura Y, Sakata K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47:5616-5619.
13. Fox RI, Kang H-I, Ando D, et al. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152:5532-5539.
14. Huang X, Yuan J, Goddark A, et al. Interferon expression in the pancreas of patients with type I diabetes. Diabetes 1995; 44:558-664.
15. Watson PF, Pickerill AP, Davies R, Weetman AP. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metabol 1994; 79:355-360.
16. Weetman AP, Cohen S, Gatter KC, Fells P, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75:222-227.
17. Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988; 29:175-184.
18. Kroll AJ, Kuwabara T. Dysthyroid ocular myopathy: anatomy, histology and electron microscopy. Arch Ophthalmol 1966; 76:244-257.
19. Heufelder AE, Bahn RS. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23:10-17.
20. McLachlan SM, Prummel MF, Rapoport B. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metabol 1994; 78:1070-1074.
21. Botazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii:1115-1119.
22. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90:6586-6590.
23. Asuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366:76-78.
24. Weetman AP. Antigen presentation in the pathogenesis of autoimmune endocrine disease. J Autoimmunity 1995, 8:305-312.
25. Hiromatsu Y, Fukazawa H, How J, Wall JR. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy - roles of class II MHC antigen expression and γ-interferon action on effector and target cells. Clin Exp Immunol 1987; 70:597-603.
26. Heufelder AE, Wenzel BE, Bahn RS. Cell surface localization of a 72 kilodalton heat shock protein in retroocular fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metabol 1992; 74:732-736.
27. Heufelder AE, Goellner JR, Wenzel BE, Bahn RS. Immunohistochemical detection and localization of a 72-kilodalton heat shock protein in autoimmune thyroid disease. J Clin Endocrinol Metabol 1992; 74:724-731.
28. Heufelder AE, Bahn RS. Modulation of intercellular adhesion molecule-1 (ICAM-1) by cytokines and Graves' IgGs in cultured Graves' retroocular fibroblasts. Eur J Clin Invest 1992; 22:529-537.
29. Heufelder AE, Bahn RS, Boergen KP, Scriba PC. Nachweis, Lokalisation und Modulation der CD44/ Hyaluronsäure-Rezeptor Expression bei Patienten mit endocriner Orbitopathie. Med Klinik 1993; 88:181-185.
30. Heufelder AE, Bahn RS. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clin Exp Immunol 1993; 92:296-302.
31. Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall JR. Demonstration of a circulating autoantibody against soluble eye muscle antigen in Graves' ophthalmopathy. Lancet 1982; 11:1353-1356.
32. Kendall-Taylor P, Atkinson S, Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J 1984; 288:1183-1186.
33. Mengistu M, Laryea EA, Miller A, Wall JR. Clinical significance of a new autoantibody against a human eye muscle soluble antigen detected by immunofluorescence. Clin Exp Immunol 1986; 65:19-27.
34. Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall JR. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J Clin Endocrinol Metabol 1986; 67:565-570.
35. Salvi M, Miller A, Wall JR. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 1988; 232:135-139.
36. Ahmann A, Baker JR, Weetman AP, Wartofsky L, Nutman TB, Burman KD. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy; identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metabol 1987; 64:454-460.
37. Hiromatsu Y, Sato M, Tanaka K, et al. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative western blot. Autoimmunity 1992; 14:9-16.
38. Kendler DL, Rootman J, Huber GK, Davies TF. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic disease. Clin Endocrinol (Oxf) 1991; 35:539-547.
39. Wall JR, Scalise D, Hayes M, et al. Native gel electrophoresis of the 64 kDa protein shows that it is eye muscle specific and an important target for autoantibodies in patients with thyroid-associated ophthalmopathy. Thyroid 1994; 4 (Suppl 1):S-92.
40. Kiljanski J, Nebes V, Wall JR. The ocular cell is a target of the immune system in endocrine ophthalmopathy. Int Arch Allergy Immunol 1995; 106:204-212.
41. Teng CS, Smith BR, Anderson J, Hall R. Comparison of thyrotropin receptors in membranes prepared from fat and thyroid tissue. Biochem Biophys Res Commun 1975; 66:836-841.
42. Perros P, Kendall-Taylor P. Demonstration of thyrotropin binding sites in orbital connective tissue: possible role in the pathogenesis of thyroid-associated ophthalmopathy. J Endocrinol Invest 1994; 17:163-170.
43. Pekonen F, Weintraub BD. Thyrotropin binding to cultured lymphocytes and thyroid cells. Endocrinology 1978; 103:1668-1677.
44. Roselli-Rehfuss L, Robbins LS, Cone RD. Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinology 1992; 130:1857-1861.
45. Paschke R, Elisei R, Vassart G, Ludgate M. Lack of evidence supporting the presence of mRNA for thyrotropin receptor in extraocular muscle. J Endocrinol Invest 1993; 16:329-332.
46. Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento EV, Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet. 1993; 342:337-338.
47. Endo T, Ohno M, Kotani S, Gunji K, Onaya T. Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Commun 1993; 190:774-779.
48. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid. 1993; 3:297-300.
49. Mengistu M, Lukses YG, Nagy EV, et al. TSH receptor gene expression in retroocular fibroblasts. J Endocrinol Invest 1994; 17:437-441.
50. Hiromatsu Y, Tanaka K, Koga M, et al. Significance of thyrotropin receptor mRNA expression in orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Endocrinol Invest 1994; 17 (Suppl 1 to 6):44.
51. Francis T, Burch HB, Cai W-Y, et al. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1991; 1:223-228.
52. Wall JR, Strakosch CR, Fang SL, Ingbar SH, Braverman LH. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol 1979; 10:79-91.
53. Benker G, Kotulla P, Kendall-Taylor P, Emrich D, Reinwein D, TSH binding-inhibiting antibodies in hyperthyroidism: relationship to clinical signs and hormone levels. Clin Endocrinol 1989; 30:19-28.
54. Chang TC, Huang KH, Chang TJ, Lin SL. Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol 1990; 32:551-555.
55. Feldt-Rasmussen U, Kemp A, Bech K, Madsen SN, Date J. Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in endocrine exophthalmos. Acta Endocrinol 1981; 96:192-198.
56. Nishikawa M, Yoshimura M, Toyoda N, et al. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy. Acta Endocrinol 1993; 129:213-219.
57. Miyake I, Koga M, Nagasawa N, et al. Clinical significance of anti-thyrotropin receptor antibodies in thyroid-associated ophthalmopathy. Thyroid 1995; 5 (Suppl 1):S185.